William Mariner Greenman
CIK 1377258 · President and CEO · last filed 2026-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.05M
Companies
3
Total Filings
76
Lifetime Open-Market Net
-$6.54M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERS | President and CEO | 5,154,955 | $2.92 | $15.05M | -$6.47M | 61 | 2026-07-02 |
| CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Director | 0 | $40.39 | $0 | -$26.9K | 6 | 2023-08-11 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | 19,835 | — | — | -$41.0K | 9 | 2020-05-28 |
Recent Filings · Page 2 of 8
76 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-11 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Disp (D) | −23,643 | $0 | EDGAR |
| 2023-05-31 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Mixed | +2,145 | -$26.9K | EDGAR |
| 2023-03-14 | CERS | Mixed | +111,712 | -$169.3K | EDGAR |
| 2023-03-03 | CERS | Grant (A) | +575,000 | $0 | EDGAR |
| 2022-05-31 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-15 | CERS | Mixed | +155,674 | -$831.6K | EDGAR |
| 2022-03-01 | CERS | Mixed | +289,237 | -$332.0K | EDGAR |
| 2021-10-22 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Exer (M) | +1,663 | $4.3K | EDGAR |
| 2021-08-05 | CERS | Exer (M) | +100,000 | $208.0K | EDGAR |
| 2021-06-07 | CHINOOK THERAPEUTICS, INC. (KDNY) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.